| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |